Emera Incorporated
EMRAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.53 | 46.75 | 0.17 | -0.61 |
| FCF Yield | -3.25% | -5.08% | -12.16% | -7.23% |
| EV / EBITDA | 13.76 | 10.39 | 11.38 | 15.50 |
| Quality | ||||
| ROIC | 3.80% | 4.31% | 3.85% | 2.98% |
| Gross Margin | 40.19% | 43.42% | 39.81% | 37.50% |
| Cash Conversion Ratio | 4.66 | 2.15 | 0.90 | 2.11 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.73% | 9.47% | 11.28% | -1.92% |
| Free Cash Flow Growth | 27.44% | 58.65% | -43.36% | -19.07% |
| Safety | ||||
| Net Debt / EBITDA | 7.68 | 6.06 | 6.55 | 7.69 |
| Interest Coverage | 1.10 | 1.91 | 2.30 | 1.52 |
| Efficiency | ||||
| Inventory Turnover | 5.51 | 5.42 | 5.94 | 6.70 |
| Cash Conversion Cycle | -42.53 | -0.99 | -28.08 | -28.06 |